Matinas BioPharma Holdings (MTNB) Restructuring Costs (2018 - 2021)
Matinas BioPharma Holdings (MTNB) posted quarterly Restructuring Costs of $15000.0 for Q4 2021, down 48.28% year-over-year from $29000.0 in Q4 2020, and down 48.28% quarter-over-quarter from $29000.0 in Q3 2021.
Matinas BioPharma Holdings (MTNB) Restructuring Costs (2018 - 2021) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Restructuring Costs for 4 consecutive years, with $15000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Restructuring Costs fell 48.28% year-over-year to $15000.0; the TTM figure through Mar 2022 stood at $72000.0 (down 68.97% YoY), while the FY2021 annual figure was $100000.0, down 65.75% from the prior year.
- Restructuring Costs slipped to $15000.0 in Q4 2021 per MTNB's latest filing, from $29000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $341828.0 in Q2 2018 and bottomed at $172.0 in Q1 2018.
- Historically, Restructuring Costs has averaged $90673.3 across 4 years, with a median of $62100.0 in 2019.
- On a YoY basis, Restructuring Costs climbed as much as 67748.84% in 2019 and fell as far as 82.83% in 2019.
- Matinas BioPharma Holdings' Restructuring Costs stood at $274000.0 in 2018, then plunged by 55.26% to $122600.0 in 2019, then sank by 76.35% to $29000.0 in 2020, then plunged by 48.28% to $15000.0 in 2021.
- Business Quant data shows MTNB's Restructuring Costs at $15000.0 in Q4 2021, $29000.0 in Q3 2021, and $28000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Matinas BioPharma Holdings | 1.19 Mn | 375,426.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 28,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Dec 31, 2020 | 29,000.00 |
| Sep 30, 2020 | 90,000.00 |
| Jun 30, 2020 | 93,000.00 |
| Mar 31, 2020 | 80,000.00 |
| Dec 31, 2019 | 122,600.00 |
| Sep 30, 2019 | 62,100.00 |
| Jun 30, 2019 | 58,700.00 |
| Mar 31, 2019 | 116,700.00 |
| Sep 30, 2018 | 274,000.00 |
| Jun 30, 2018 | 341,828.00 |
| Mar 31, 2018 | 172.00 |